XYL
49
4
HP
48
3
WFC
79
4
CMG
72
5
GPC
40
3
YUM
47
3
EOG
58
2
GIS
31
3
FDX
43
3
PSA
58
2
GOOG
50
-3
IR
66
3
NSC
60
3
DRI
53
5
WY
54
4
COF
60
2
CPB
30
6
WDC
47
4
PVH
62
5
LRCX
43
-2
XYL
49
4
HP
48
3
WFC
79
4
CMG
72
5
GPC
40
3
YUM
47
3
EOG
58
2
GIS
31
3
FDX
43
3
PSA
58
2
GOOG
50
-3
IR
66
3
NSC
60
3
DRI
53
5
WY
54
4
COF
60
2
CPB
30
6
WDC
47
4
PVH
62
5
LRCX
43
-2
Financhill
Back

Editas Medicine Vs. Regenxbio Industry Stock Comparison

Sell
40

EDIT
Editas Medicine

Last Price:
2.44
Seasonality Move:
13.73%
Sell
26

RGNX
Regenxbio

Last Price:
9.60
Seasonality Move:
-5.7%
Sell
40
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.44. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.59. The Score for RGNX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing slight buying pressure.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 33.29 Sell
Chaikin Money Flow: 166015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.64 - 3.32) Sell
Bollinger Bands (100): (2.97 - 4.75) Sell

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 46.66 Sell
Chaikin Money Flow: 300118 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.94 - 10.6) Sell
Bollinger Bands (100): (9.84 - 12.8) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.58 Sell
20-day SMA: 2.89 Sell
50-day SMA: 3.21 Sell
200-day SMA: 5.21 Sell
8-day EMA: 2.58 Sell
20-day EMA: 2.83 Sell
50-day EMA: 3.21 Sell
200-day EMA: 4.98 Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.95 Sell
20-day SMA: 9.79 Sell
50-day SMA: 10.29 Sell
200-day SMA: 14.24 Sell
8-day EMA: 9.79 Sell
20-day EMA: 9.92 Sell
50-day EMA: 10.36 Sell
200-day EMA: 13.18 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):